Join
Live feed
·
PRReleasevia Quantisnow
Navidea Biopharmaceuticals Inc. logo

Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAVB (Navidea Biopharmaceuticals Inc.) and more on Quantisnow.